Haemolytic-uraemic syndrome: survival after prolonged oliguria.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000150:complications* / Q000188:drug therapy; D001002:Anuria / Q000401:mortality / Q000628:therapy*; D001792:Blood Platelets; D002675:Child, Preschool; D004231:Diuresis; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D013290:Streptococcal Infections / Q000150:complications; D013997:Time Factors; D014511:Uremia / Q000150:complications* / Q000517:prevention & control
D000324:Adrenocorticotropic Hormone; D006493:Heparin